Table 1.
Clinical and pathological characteristics of the Hodgkin lymphoma patients studied for GLUT1 and LDHA expression
| HL cases | Membrane bound GLUT1 expression | Cytoplasmic LDHA expression | |
|---|---|---|---|
| N |
207 |
102/207 (49%) |
68/153 (44%) |
| Age, median in years |
34 |
|
|
| Gender, male (%) |
48 |
|
|
| Histology |
|
|
|
| -Nodular sclerosis |
140 |
79/140 (56%) |
44/97 (45%) |
| -Mixed cellularity |
29 |
12/29 (41%) |
8/22 (36%) |
| -Lymphocyte-rich |
10 |
3/10 (30%) |
3/10 (30%) |
| -Lymphocyte-depleted |
6 |
6/6 (100%) |
4/6 (67%) |
| -NOS (not classifiable) |
9 |
0/9 (0%) |
3/5 (60%) |
| -Lymphocyte predominant |
13 |
2/13 (15%) |
6/13 (46%) |
| Stage (%) |
|
|
|
| - I |
2 |
|
|
| - II |
89 |
|
|
| - III |
37 |
|
|
| - IV |
25 |
|
|
| B-Symptoms (%) |
46 |
|
|
| Bulky disease (%) |
32 |
|
|
| Interim-PET positive (%) |
18 |
|
|
| Treatment |
|
|
|
| - ABVD (%) |
80 |
|
|
| - ABVD + radiation (%) | 20 |